
The Weekly Roundup: July 22-26
In case you missed it, this week we had news about the FDA approval of deuruxolitinib for severe alopecia in adults, new nonmelanoma guidelines from the Dermatology Association of Radiation Therapy, Arcutis' submitted sNDA for roflumilast foam for scalp and body psoriasis, and more.
To stay up-to-date with the latest dermatology news, sign up to receive our
Clinical Insights Into Challenging Atopic Dermatitis Cases: Part 3
Robert Posnick, MD, hosted a Case-Based Roundtable discussion to review 2 challenging cases of atopic dermatitis involving hyperpigmentation and alopecia areata.
Type 1 Diabetes is a Risk Factor for Vitiligo Development, Study Reports
Researchers examined the role of diabetes and glycemic profile in the risk of development of vitiligo in a Mendelian randomization study.
New Clinical Guidelines for Nonmelanoma Skin Cancer Published by Dermatology Association of Radiation Therapy
The guidelines for BCC and SCC treatment with IGSRT detail diagnosis, staging, contraindications, protocols, and emphasize the essential role of a multidisciplinary team.
Oral Dimethyl Fumarate Improves All Disease Classification Criteria in Plaque Psoriasis
Oral dimethyl fumarate improved all disease classification criteria for plaque psoriasis, showing significant betterment of severity and quality of life.
Evaluating the Efficacy and Perception of HS Treatment Options
Spherix Global Insights recently delved into the efficacy, patient quality of life, and symptom management of adalimumab vs secukinumab.
Expert Reflections: Mentors Elevating Careers
In a milestone year for Dermatology Times, our Editorial Advisory Board reflects on key career mentors.
Offering an Insurance Package to Retain and Reward Employees: What Dermatologists Should Know
Explore various elements that can go into a comprehensive insurance benefits package for dermatology practice employees.
Arcutis Submits sNDA for Roflumilast Foam to FDA for Scalp and Body Psoriasis
The submission to the FDA is supported by positive results from the ARRECTOR phase 3 trial.
The Interplay Between Sleep Disorders and Dermatology
A recent review investigated all known information between skin conditions and sleep disorders, finding a bidirectional influence between them.
Study Reports High Frequency of Emergency Complications During Dermatological, Surgical, and Cosmetic Procedures
Researchers noted that many dermatologists face mild, non-life-threatening complications during procedures, yet must be prepared for emergencies.
Skin Manifestations More Common Than Internal Organ Involvement in Sjögren Syndrome
A recent study examined skin manifestations and SS from a dermatological perspective.
Live From Chicago: Bringing Sun Protection Awareness to Communities
Renata Block, MMS, PA-C, interviews dermatology clinicians and the Melanoma Research Foundation CEO at the Chicago SPF Fest.
Latex Gloves and the Americans With Disabilities Act
Of those who have reported latex allergy, approximately 75% are health care workers. What should practice owners and managers need to consider legally?
Managing Food Allergies with Dupilumab in Pediatric Dermatology
A recent study saw a “significant” decrease in allergen-specific IgE levels over a 1-year period of dupilumab therapy in children with atopic dermatitis.
Deep Histological Margins Do Not Increase cSCC Recurrence Risk if Tumor is Fully Excised
Margins < 1 mm also do not increase the risk of cutaneous squamous cell carcinoma recurrence risk if the galea aponeurotica is not involved.
Physicians Should Prepare for Potential Acne Vulgaris Misinformation Correction, Report Says
Social media misinformation related to acne vulgaris may require clinician intervention when discussing treatment with patients.
Insights into Bimekizumab 2-Year Data for PsA, nr-asSpA, and AS
Researchers behind the phase 3 studies gave pearls into the study methods, results, and what is up next.
First Study Reveals Covariate-Adjusted Effects of New Actinic Keratosis Therapies for Face and Scalp
Data from numerous studies identified fluorouracil 5% as ranking the most effective across 3 outcomes.
Xkin Suture Device Acts as Effective Wound Closure Method, Improves Scar Outcomes
Compared to a stapling device, Xkin reduced scarring, pain, and infection risk more effectively in surgical and trauma wounds.
Rituximab May Provide Alternative Treatment Option for Epidermolysis Bullosa Acquisita
A systematic review of 31 studies found that patients with EBA responded well to rituximab with few adverse effects.
Combining Microneedling and Tranexamic Acid for Melasma: Efficacy and Satisfaction
The study highlights the need for personalized treatments, suggesting that this combination therapy is most beneficial when tailored to individual risk profiles.
Expert Reflections: Impact of Dermatology Times
In a milestone year for Dermatology Times, our Editorial Advisory Board reflects on how the publication has impacted their practice.
Electroablation Plus Pharmacotherapy Leads to Reduction in Keloid Volume
Combining electrocoagulation with pharmacotherapy significantly reduced keloid scar volume by inhibiting collagen deposition, angiogenesis, and cell proliferation.
The FDA Approves Deuruxolitinib for Severe Alopecia in Adults
Along with the approval, Sun Pharma is introducing an access program to assist eligible patients in starting and adhering to the treatment.
Study Highlights Efficacy of Lotion with Biotechnological Phytocomplex, Niacinamide, and Succinic Acid in Enhancing Microbiota Diversity and Reducing Acne Severity
The lotion effectively rebalanced the microbiota, reduced erythema and desquamation, and improved acne severity.
Social Media and Psoriasis: Addressing Misinformation on TikTok
A recent study found psoriasis content deemed “unreliable” still obtained 850,000 likes.
Emerging Therapeutic for Non-Segmental Vitiligo: Merck’s MK-6194
Iltefat Hamzavi, MD, discusses the REGINA 007 phase 2 trial evaluating MK-6194 for the treatment of non-segmental vitiligo.
Complex Relationship Between Air Pollutants and Secondary Sensitive Skin in Patients With Acne
Investigators looked into pollutant-induced disruption of the skin barrier, increased transepidermal water loss, and heightened inflammatory responses.
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.


















